与接受PTCy预防的年龄较大的匹配同胞供体造血干细胞移植相比，接受年龄较小的HLA匹配无关供体造血干细胞移植可提高生存率。 - Suppr

Suppr

超能文献

Improved survival with younger HLA-matched unrelated donors versus older matched sibling donor HCT with PTCy-prophylaxis.

作者信息

Ramdial Jeremy, Kebriaei Partow, Champlin Richard E, Popat Uday, Rezvani Katayoun, Shpall Elizabeth J, Mehta Rohtesh S

机构信息

MD Anderson Cancer Center, Houston, TX, USA.

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.

出版信息

Leukemia. 2024 Jun;38(6):1432-1434. doi: 10.1038/s41375-024-02256-0. Epub 2024 May 2.

DOI:10.1038/s41375-024-02256-0

PMID:38698071

Abstract

摘要

相似文献

Improved survival with younger HLA-matched unrelated donors versus older matched sibling donor HCT with PTCy-prophylaxis.

Leukemia. 2024 Jun;38(6):1432-1434. doi: 10.1038/s41375-024-02256-0. Epub 2024 May 2.

Haploidentical Versus Mismatched Unrelated Donor Hematopoietic Cell Transplantation: HLA Factors and Donor Age Considerations.

Transplant Cell Ther. 2024 Sep;30(9):909.e1-909.e11. doi: 10.1016/j.jtct.2024.07.005. Epub 2024 Jul 10.

Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial.

J Clin Oncol. 2015 Apr 10;33(11):1265-74. doi: 10.1200/JCO.2014.58.9747. Epub 2015 Mar 9.

Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.

J Clin Oncol. 2016 Sep 10;34(26):3141-9. doi: 10.1200/JCO.2015.66.3476. Epub 2016 Jun 6.

Allogeneic hematopoietic stem cell transplantation from sibling and unrelated donors in pediatric patients with sickle cell disease-A single center experience.

Pediatr Transplant. 2021 Mar;25(2):e13892. doi: 10.1111/petr.13892. Epub 2020 Oct 24.

Combined effect of unrelated donor age and HLA peptide-binding motif match status on HCT outcomes.

Blood Adv. 2024 May 14;8(9):2235-2242. doi: 10.1182/bloodadvances.2024012669.

Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.

PLoS One. 2016 Jun 24;11(6):e0158242. doi: 10.1371/journal.pone.0158242. eCollection 2016.

Single Antigen-Mismatched Unrelated Hematopoietic Stem Cell Transplantation Using High-Dose Post-Transplantation Cyclophosphamide Is a Suitable Alternative for Patients Lacking HLA-Matched Donors.

Biol Blood Marrow Transplant. 2018 Jun;24(6):1196-1202. doi: 10.1016/j.bbmt.2018.01.021. Epub 2018 Feb 2.

Bone Marrow Transplant. 2014 May;49(5):671-8. doi: 10.1038/bmt.2014.4. Epub 2014 Feb 10.

Cytomegalovirus Reactivations in Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Matched and Haploidentical Donors with Post-Transplantation Cyclophosphamide.

Transplant Cell Ther. 2024 May;30(5):538.e1-538.e10. doi: 10.1016/j.jtct.2024.01.082. Epub 2024 Feb 6.

引用本文的文献

Leukemia. 2025 Aug 6. doi: 10.1038/s41375-025-02724-1.

Haploidentical vs HLA-matched sibling donor HCT with PTCy prophylaxis: HLA factors and donor age considerations.

Blood Adv. 2024 Oct 22;8(20):5306-5314. doi: 10.1182/bloodadvances.2024013853.

本文引用的文献

Post-transplantation cyclophosphamide is associated with increased bacterial infections.

Bone Marrow Transplant. 2024 Jan;59(1):76-84. doi: 10.1038/s41409-023-02131-z. Epub 2023 Oct 31.

Younger Matched Unrelated Donors Confer Decreased Relapse Risk Compared to Older Sibling Donors in Older Patients with B Cell Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.

Transplant Cell Ther. 2023 Oct;29(10):611-618. doi: 10.1016/j.jtct.2023.07.015. Epub 2023 Jul 21.

Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.

N Engl J Med. 2023 Jun 22;388(25):2338-2348. doi: 10.1056/NEJMoa2215943.

Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors.

JAMA Oncol. 2022 Mar 1;8(3):404-411. doi: 10.1001/jamaoncol.2021.6846.

HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis.

Blood. 2021 Jul 22;138(3):273-282. doi: 10.1182/blood.2021011281.

Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most.

Biol Blood Marrow Transplant. 2018 May;24(5):1049-1056. doi: 10.1016/j.bbmt.2018.02.006. Epub 2018 Feb 14.

Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?

Blood. 2013 Mar 28;121(13):2567-73. doi: 10.1182/blood-2012-08-453860. Epub 2013 Jan 29.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验